Viewing Study NCT01437618


Ignite Creation Date: 2025-12-25 @ 4:56 AM
Ignite Modification Date: 2025-12-26 @ 3:56 AM
Study NCT ID: NCT01437618
Status: COMPLETED
Last Update Posted: 2011-09-21
First Post: 2011-07-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: First-line FOLFOXIRI Plus Bevacizumab in BRAF Mutant Metastatic Colorectal Cancer
Sponsor: Azienda Ospedaliero, Universitaria Pisana
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module